Recall archive / FDA drug enforcement
Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc... — FDA record D-0077-2023
Reported terminated
Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.
Source date Dec 5, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
What the record says
- Product
- Desmopressin Acetate Tablet, 0.2 mg, 100-count box, Rx only, Source NDC: 23155-0490-01; MFG: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816; Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC #: 70518-3493-00.
- Reason
- Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.
- Classification
- Class II
- Recalling firm
- RemedyRepack Inc.
- Quantity
- 9 boxes
- Agency-reported status
- Terminated
- Source record identifier
- D-0077-2023
What the recall classes mean. Classification is an agency assessment, not individual medical advice.
Lot and product identifiers
| Label field | Details supplied by the agency |
|---|---|
| Lot, code or applicability | Lot # B1817019-082222, Exp. 02/24/2023; B1819127-082322, Exp. 02/26/2023 |
Match all identifying details in the current notice. A brand name alone is not enough.
Distribution
Product was distributed to two different customers in MI.
States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.
Dates in the source
- Report date
- Dec 14, 2022
- Recall initiation date
- Dec 5, 2022
- Center classification date
- Dec 7, 2022
- Termination date
- Feb 3, 2023
FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.